9 drug(s) with this reaction
9,681 total reports
Back Pain has been reported as an adverse reaction across 9 drug(s) manufactured by Amgen Inc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 9,681 adverse event reports mention back pain in connection with Amgen Inc products.
This page provides a breakdown of which Amgen Inc drugs are most commonly associated with back pain, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Amgen Inc drugs have back pain listed in their FDA adverse event reports, sorted by report count:
In addition to back pain, the following adverse reactions have been reported across Amgen Inc's drug portfolio:
9 drug(s) manufactured by Amgen Inc have back pain listed in their FDA adverse event reports: DENOSUMAB, PEGFILGRASTIM, FILGRASTIM, DARBEPOETIN ALFA, ROMOSOZUMAB-AQQG, and others.
There are a combined 9,681 reports of back pain across 9 Amgen Inc drug(s) in the FDA adverse event database.